Company & Sponsor Intelligence

University of Missouri-Columbia

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials9

Recruiting3

Completed3

Countries1

Therapeutic footprint

autismdementia_otherepilepsyother_neurologyother_psychiatry

Indexed studies

NCT01126957Combined Ketamine/Propofol for Emergency Department Procedural Sedation
other_neurology · United StatesNA

NCT01352611Open Label Treatment of Severe Tactile Defensiveness With Intrathecal Baclofen
autism · United StatesNA

NCT03610763Harnessing Neuroplasticity to Enhance Functional Recovery During Chronic Recovery From Upper Extremity Nerve Repair
other_neurology · United StatesNA

NCT02871349Trial of Propranolol in Children and Youth With Autism Spectrum Disorder and Predictors of Response
autism · United StatesEARLY_PHASE1

NCT07329257Investigating Phenotypic, Epigenetic, and NeuroGenetic Traits in Rare and Ultra-rare Neurodevelopmental Disorders (Project PENGUIN)
epilepsy · United StatesRECRUITING

NCT03625297Shelter Cat Adoption in Families of Children With Autism (Feline Friends)
autism · United StatesNA

NCT03960138Examining the Effects of Neural Stimulation on Inhibitory Control and Cigarette Smoking
other_psychiatry · United StatesNA

NCT06480708Evaluation of the Ketogenic Diet to Improve Post Operative Cognitive Decline in Cardiac Surgery
dementia_other · United StatesNA

NCT07216196The Feasibility of a Remote Problem-Solving Intervention for Autistic Adolescents or Young Adults and a Caregiver
autism · United StatesNA

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →